LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
44.96
-0.54 (-1.18%)
Jun 17, 2025, 12:12 PM - Market open
LivaNova Market Cap
LivaNova has a market cap or net worth of $2.45 billion as of June 17, 2025. Its market cap has decreased by -25.57% in one year.
Market Cap
2.45B
Enterprise Value
2.38B
1-Year Change
-25.57%
Ranking
Category
Stock Price
$44.96
Market Cap Chart
Since October 19, 2015, LivaNova's market cap has decreased from $3.42B to $2.45B, a decrease of -28.21%. That is a compound annual growth rate of -3.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 2.48B | -1.34% |
| Dec 31, 2024 | 2.51B | -9.78% |
| Dec 29, 2023 | 2.79B | -6.24% |
| Dec 30, 2022 | 2.97B | -36.12% |
| Dec 31, 2021 | 4.65B | 44.63% |
| Dec 31, 2020 | 3.22B | -11.87% |
| Dec 31, 2019 | 3.65B | -18.02% |
| Dec 31, 2018 | 4.45B | 15.57% |
| Dec 29, 2017 | 3.85B | 75.67% |
| Dec 30, 2016 | 2.19B | -24.35% |
| Dec 31, 2015 | 2.90B | -15.10% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.99B |
| Johnson & Johnson | 373.47B |
| Novo Nordisk | 343.59B |
| AbbVie | 337.14B |
| UnitedHealth Group | 279.09B |
| Abbott Laboratories | 233.16B |
| Novartis AG | 232.80B |
| AstraZeneca | 228.09B |